Skip to main content

Table 1 Patient characteristics, preoperative and intraoperative findings, and pathology

From: Introducing navigation during melanoma-related sentinel lymph node procedures in the head-and-neck region

 

Preoperative findings

Intraoperative findings

Pathology

 

Age

Clinical T-stage

Tumor location

Administered dose (MBq)

No. of SNs on lymphoscintigrams

No. of SNs on SPECT/CT

Location SNs

Total no. of removed SNs

Fluorescent SNs

Radioactive SNs

Total no. of SNs

No. tumor-positive nodes

         

In vivo

Ex vivo

In vivo

Ex vivo

  

1

60

T2a

Right cheek

82.0

0

4

Parotid gland (2×), level I (2×)

4

3

4

4

4

4

0

2

74

T2b

Left cheek

84.9

3

3

Parotid gland, level II, level V

4

4

4

4

4

6

0

3

67

Right eyelid

84.4

1

1

Parotid gland

1

1

1

1

1

1

0

4

52

T3b

Right cheek

78.2

1

1

Level V

1

1

1

1

1

1

0

5

59

T4b

Left occipital region

90.2

1

1

Level V

1

1

1

1

1

1

1

6

63

T3a

Right occipital region

101.4

0

1

Level II

3

3

3

3

3

4

0

7

66

T2a

Vertex

75.5

2

2

Level II (2×)

3

3

3

3

3

4

0

8

43

T3a

Left ear

90.1

2

2

Parotid gland, level II

3a

3

3

3

3

3

1

Average

60.5

  

85.8

1.25

1.9

 

2.5

2.4

2.5

2.5

2.5

3

 

Total

    

10

15

 

20

19

20

20

20

24

2

  1. MBq megabequerel, SN sentinel node, SPECT/CT single-photon emission computed tomography combined with computed tomography
  2. aAdditional SN near injection site found with transcutaneous fluorescence imaging (and confirmed using the gamma probe) which was not seen on preoperative imaging